These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Phase II trial of weekly irinotecan/cisplatin in advanced esophageal cancer. Ilson DH Oncology (Williston Park); 2004 Dec; 18(14 Suppl 14):22-5. PubMed ID: 15685830 [TBL] [Abstract][Full Text] [Related]
7. Treatment of non-small-cell lung cancer in North America: the emerging role of irinotecan. Langer CJ Oncology (Williston Park); 2001 Jan; 15(1 Suppl 1):19-24. PubMed ID: 11221017 [TBL] [Abstract][Full Text] [Related]
8. Irinotecan plus cisplatin in patients with advanced non-small-cell lung cancer. Devore R; Johnson D; Crawford J; Dimery I; Eckardt J; Eckhardt SG Oncology (Williston Park); 1998 Aug; 12(8 Suppl 6):79-83. PubMed ID: 9726097 [TBL] [Abstract][Full Text] [Related]
9. Irinotecan, cisplatin, and radiation in esophageal cancer. Ilson DH; Minsky B; Kelsen D Oncology (Williston Park); 2002 May; 16(5 Suppl 5):11-5. PubMed ID: 12109799 [TBL] [Abstract][Full Text] [Related]
10. The emerging world role of irinotecan in lung cancer. Langer CJ Oncology (Williston Park); 2001 Jul; 15(7 Suppl 8):15-21. PubMed ID: 11497227 [TBL] [Abstract][Full Text] [Related]
11. Irinotecan plus cisplatin in advanced gastric or gastroesophageal junction carcinoma. Ajani JA; Baker J; Pisters PW; Ho L; Feig B; Mansfield PF Oncology (Williston Park); 2001 Mar; 15(3 Suppl 5):52-4. PubMed ID: 11301842 [TBL] [Abstract][Full Text] [Related]
12. Role of topoisomerase I inhibitors in small-cell lung cancer. Fukuoka M Oncology (Williston Park); 2001 Jul; 15(7 Suppl 8):9-13. PubMed ID: 11497234 [TBL] [Abstract][Full Text] [Related]
13. Irinotecan and cisplatin in advanced gastric or gastroesophageal junction carcinoma. Ajani JA; Fairweather J; Pisters PW; Charnsangavej C Oncology (Williston Park); 2000 Dec; 14(12 Suppl 14):19-21. PubMed ID: 11200143 [TBL] [Abstract][Full Text] [Related]
16. Establishment of the standard regimen for non-small-cell lung cancer in Japan. Masuda N Oncology (Williston Park); 2001 Jan; 15(1 Suppl 1):13-8. PubMed ID: 11221016 [TBL] [Abstract][Full Text] [Related]
17. The role of irinotecan and oxaliplatin in the treatment of advanced colorectal cancer. Khayat D; Gil-Delgado M; Antoine EC; Nizri D; Bastian G Oncology (Williston Park); 2001 Apr; 15(4):415-29; discussion 429-30, 433-4. PubMed ID: 11346931 [TBL] [Abstract][Full Text] [Related]
18. Irinotecan for the treatment of cervical cancer. Verschraegen CF Oncology (Williston Park); 2002 May; 16(5 Suppl 5):32-4. PubMed ID: 12109804 [TBL] [Abstract][Full Text] [Related]
19. Topoisomerase I inhibitors in the treatment of colorectal cancer. Rothenberg ML; Blanke CD Semin Oncol; 1999 Dec; 26(6):632-9. PubMed ID: 10606256 [TBL] [Abstract][Full Text] [Related]
20. Combined modality therapy in esophageal cancer: the Memorial experience. Anderson SE; Minsky BD; Bains M; Kelsen DP; Ilson DH Semin Surg Oncol; 2003; 21(4):228-32. PubMed ID: 14648780 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]